Targeting small extracellular vesicle-mediated cardiomyocyte-adipocyte pathological communication may be a therapeutic strategy to prevent metabolic dysfunction after myocardial ischemia/reperfusion.
We demonstrate for the first time that MI/R causes significant adipocyte ER stress and endocrine dysfunction by releasing miR-23-27-24 cluster-enriched small extracellular vesicle. Targeting small extracellular vesicle-mediated cardiomyocyte-adipocyte pathological communication may be of therapeutic potential to prevent metabolic dysfunction after MI/R.
Gan et al. (Fri,) studied this question.